Vasorin is a potential serum biomarker and drug target of hepatocarcinoma screened by subtractive-EMSA-SELEX to clinic patient serum

We report a new biomarker of hepatocarcinoma, vasorin (VASN), screened by a subtractive EMSA-SELEX strategy from AFP negative serum of hepatocellular carcinoma (HCC) patients with extrahepatic metastases. VASN was verified to be highly expressed in sera of 100 cases of HCC patients compared with 97...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Li, Shaohua, Li, Hui, Yang, Xiqin, Wang, Wei, Huang, Aixue, Li, Jie, Qin, Xingliang, Li, Fei, Lu, Guanyi, Ding, Hongmei, Su, Xueting, Hou, Lvbin, Xia, Wei, Shi, Ming, Zhang, Hongwen, Zhao, Qiang, Dong, Jie, Ge, Xingfeng, Sun, Leqiao, Bai, Chenjun, Wang, Chaonan, Shen, Xuelian, Fang, Tao, Wang, Fusheng, Zhang, Heqiu, Shao, Ningsheng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2015
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4496339/
https://ncbi.nlm.nih.gov/pubmed/25826090
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak